Everett Moding

23PUBLICATIONS
204CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEndocrinologyTumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Mar 05, 2026
Neoadjuvant BO-112 and Hypofractionated Radiation Therapy with or without Nivolumab in Soft-Tissue Sarcoma: Preclinical and Phase I Results.

Jie Deng, Aastha Pal, Stefano Testa

|Feb 12, 2026
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma.

Evan Rosenbaum, Fiona Ehrich, Mohammad Yosofvand

|Nov 24, 2025
Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032.

Stefano Testa, Jonathon E Himes, Ajay Subramanian

|Sep 27, 2025
Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout.

Jacqueline Oliva-Ramirez, David Milewski, Lauren Banks

|Sep 26, 2025
Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma.

Ajay Subramanian, Shengqin Su, Jamie Flerlage

|May 26, 2025
Tegavivint triggers TECR-dependent nonapoptotic cancer cell death.

Logan Leak, Ziwei Wang, Alby J Joseph

Pageof 4

Frequent Collaborators

9 joint publications

Maximilian Diehn

9 joint publications

Ash A Alizadeh

6 joint publications

Ajay Subramanian

6 joint publications

Barzin Y Nabet